Showing results (541-550 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|March 30, 2018
Effects of Intranasal Oxytocin Administration on Sexual Functions in Healthy Women: A Laboratory ParadigmTillmann H C Kruger, Frank Deiter, Yuanyuan Zhang, et al.Journal of Clinical Psychopharmacology|October 1, 1988
Metabolism of thioridazine in the elderlyB M Cohen, B R SommerJournal of Clinical Psychopharmacology|December 14, 2019
Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine InfusionsRoman M Dale, Kelly A Bryant, Nicolas R ThompsonJournal of Clinical Psychopharmacology|June 28, 2021
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the MorningHubert Bland, Xiaodong Li, Eric Mangin, et al.Journal of Clinical Psychopharmacology|June 24, 2021
Quetiapine in the Anxiety Dimension of Mood Disorders: A Systematic Review of the Literature to Support Clinical PracticeCalogero Crapanzano, Stefano Damiani, Cecilia GuiotJournal of Clinical Psychopharmacology|December 6, 2018
Switching to Imipramine Versus Add-on Mirtazapine in Venlafaxine-Resistant Major Depression: A 10-Week Randomized Open StudyVíctor Navarro, Ilham Boulahfa, Amadeu Obach, et al.Journal of Clinical Psychopharmacology|December 12, 2018
Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled StudyKarin Göhler, Marta Sokolowska, Kerri A Schoedel, et al.Journal of Clinical Psychopharmacology|June 24, 2022
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Aluri, et al.Journal of Clinical Psychopharmacology|June 21, 2022
Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative StudyMasanobu Kogure, Nobuhisa Kanahara, Makoto Kimura, et al.Journal of Clinical Psychopharmacology|June 28, 2022
Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern IndiaSandeep Grover, Chandrima Naskar, Subho ChakrabartiPageof 332